Blog | HemaCare

Improved Outcome for Stem Cell Transplantation in Leukemia

Sep 28, 2015 1:00:14 PM / by Daisy posted in GVHD, Bone marrow, clinical trial, leukemia, research, stem cells, T cells

0 Comments

About 50% of stem cell transplant patients develop GVHD. A clinical trial using a modified stem cell graft reduced this hazard to 9%.

Read More

Gut Bacteria Influence Outcome of Stem Cell Transplantation

Jun 24, 2015 1:00:06 PM / by Daisy posted in GVHD, human microbiome project, research

0 Comments

Clinical team finds gut microbiota in cancer patients could predict the outcome of their stem cell transplantation

Read More

Tregs opens up Exciting Opportunities for Cell Based Therapies

Sep 22, 2014 1:00:40 PM / by Shweta posted in GMP, GVHD, leukapheresis, cell therapy, cGMP, clinical grade compliance, Innovation, research, T lymphocytes, white blood cells, whole blood

0 Comments

Manufacturing of clinical grade Tregs for cell based therapies

Read More

Donor T regs Friendly Towards Host Dendritic Cells

Apr 23, 2014 1:00:50 PM / by Daisy posted in GVHD, Dendritic cells, research, T cells

0 Comments

Research on T regs indicates that they could be used for therapeutic purposes in GVHD. Image credits: clker.com
Read More

Dendritic Cells: Rabble-Rousers after Stem Cell Transplantation

Apr 16, 2014 1:00:50 PM / by Daisy posted in GVHD, proteasome inhibitors, research, T cells

0 Comments

Stem cell transplantation is often the only option for patients who have certain blood cancers. Unfortunately, this last resort can sometimes bring more harm than good. Graft versus host disease (GVHD), is a common complication that affects 50% of transplant patients. GVHD is not an issue if the patient's own stem cells are transplanted back. However, GVHD can become an issue, sometimes fatal, when stem cells from another donor are used.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts